AGP Executive Report
Last update: 5 hours agoVaccine Safety Update: The EMA’s PRAC recommends restricting the chikungunya vaccine Ixchiq to people at high infection risk after a safety review flagged serious adverse events, including hospitalizations and deaths. Obesity Coverage Shift: France becomes the first EU country to reimburse GLP-1 weight-loss drugs Wegovy and Mounjaro starting June 15, with strict BMI and specialist-prescription rules. Medicare Pressure & Access: New reporting highlights how Medicare brokers’ commissions can steer retirees toward worse plans, while other coverage notes Medicare’s ongoing funding crunch and rising costs. Maternal Syphilis Drug Shortage: The U.S. faces a shortage of the only first-line congenital syphilis prevention medicine for pregnant patients, with supply delays expected until late 2027. Clinical Tech at the Bedside: AIIMS Bhopal plans a “digital decision partner” to standardize diagnosis and dosing across specialties. Rural Care & Innovation: A new TV segment spotlights how a rural Idaho hospital uses robotics and tech to stabilize access. Public Health & Safety: Pakistan faces concerns over improper medical waste disposal, and NAFDAC warns Nigeria about a U.S. recall of contaminated children’s ibuprofen.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
